Federal State Budgetary Institution, Research Institute for Complex Issues of Cardiovascular Diseases, Kemerovo, The Russian Federation.
Federal State Budget Educational Institution of Higher Education, Kemerovo State Medical University of the Ministry of Healthcare of the Russian Federation, Kemerovo, The Russian Federation.
PLoS One. 2019 Jun 7;14(6):e0208156. doi: 10.1371/journal.pone.0208156. eCollection 2019.
The aim of this study was to determine the relationship between the thickness of epicardial adipose tissue (EAT) and perivascular adipose tissue (PVAT) and the adipokine-cytokine profile of patients with coronary heart disease, which can be of significant importance for predicting the course of cardiovascular disease (CVD). Eighty-four patients with CVD were assessed and divided into two groups based on the presence of visceral obesity (VO). In patients with VO, the thickness of the epicardial deposits of the left and right ventricles were 1.75 and 1.43 times greater, respectively, than in patients without VO. For patients with VO, the prevalence of the volume of the left anterior descending artery was 10% higher, and the middle third of the envelope artery was 28% higher, when compared to patients without VO. When evaluating inflammatory status, it was established that the concentration of tumor necrosis factor-α, interleukin (IL)-1β, and leptin in the blood serum of patients with VO exceeded the values of patients without VO. The level of anti-inflammatory IL-10 was 2-times lower in patients with VO. The findings of this study show that increased EAT and PVAT are independent risk factors of CVD, as well as a possible model for the assessment of drug effectiveness for CVD.
本研究旨在确定心外膜脂肪组织(EAT)和血管周围脂肪组织(PVAT)厚度与冠心病患者的脂肪因子-细胞因子谱之间的关系,这对于预测心血管疾病(CVD)的病程可能具有重要意义。评估了 84 例 CVD 患者,并根据是否存在内脏肥胖(VO)将其分为两组。在存在 VO 的患者中,左、右心室的心外膜沉积物厚度分别增加了 1.75 倍和 1.43 倍。与无 VO 的患者相比,VO 患者的左前降支动脉容积的发生率高 10%,包络动脉中段的发生率高 28%。在评估炎症状态时,发现 VO 患者血清中肿瘤坏死因子-α、白细胞介素(IL)-1β和瘦素的浓度超过了无 VO 患者的值。VO 患者的抗炎性 IL-10 水平低 2 倍。本研究的结果表明,增加的 EAT 和 PVAT 是 CVD 的独立危险因素,也是评估 CVD 药物疗效的可能模型。